Cookie Yu joined Merck Ventures as an analyst to support portfolio management in January 2018. Cookie studied Biomedical Engineering at Stony Brook University; she is currently working towards her PhD degree and has completed the CFA Level I course. Cookie’s research focused on method development for various cellular assays in the fields of cardiac optogenetics and single cell analysis. During her time in academia, Cookie has participated in the early commercialization preparation in collaboration with the Center of Biotechnology at Stony Brook University. She has led the market and prior-art research for a single-cell technology and financial modeling for a colorectal cancer treatment. Cookie is based in Darmstadt.